The homepage of the GSK USA website. April 09 2025 GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025 ; March 25 2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and pediatric patients 12 years of age and older

Latest press releases. April 09 2025 GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025 ; March 25 2025 Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and pediatric patients 12 years of age and older

Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations. If you are a healthcare professional, you can access more product information on our GSKPro website.. In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center.

Ahead Together. At GSK, we unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

April 09 2025 GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025. GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education.

Get in touch USA Pennsylvania Address: GSK 2929 Walnut Street Ste. 1700 Philadelphia, PA 19104. North Carolina Address: GSK 410 Blackwell St. Durham, NC 27701

Life at GSK. We are transforming our culture to create an environment where individuals and teams are inspired to be ambitious for patients

Oct 24, 2024 · GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines The new R&D and commercial facilities will double the size and capacity of the site, creating over 200 new jobs in the region

We are a focused biopharma company. We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas - respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. ...

We believe that together through clinical studies we can make a difference in the lives of people who are at risk for a disease, who are already living with it, or who want to help prevent diseases in others. Learn about our approach to clinical studies, how we work with doctors and patients throughout this process, and why we believe it is important we have people in our clinical …